论文部分内容阅读
目的:对重症慢性呼吸道疾病合并侵袭性肺曲霉病(CRD&IPA)的临床特点进行总结和探究,为该病的早期诊断与治疗提供依据。方法:将入住我院的96例重症慢性呼吸道疾病患者的资料进行回顾性分析,并对侵袭性肺曲霉进行分离。结果:在上述CRD患者之中,确定有IPA的患者有22例,占整个CRD患者的22.9%。在22名CRD&IPA患者中,已经确诊5例,临床诊断为13例,4例拟诊,分别占CRD&IPA患者的22.7%、59.1%、18.2%。结论:CRD&IPA并非为少见症状,预后差,因此需要加强对CRD&IPA的诊断,以尽快使医生确定治疗方案。
Objective: To summarize and explore the clinical features of severe chronic respiratory disease complicated with invasive pulmonary aspergillosis (CRD & IPA), and to provide evidence for the early diagnosis and treatment of the disease. Methods: The data of 96 patients with severe chronic respiratory diseases admitted to our hospital were retrospectively analyzed and the invasive pulmonary aspergillus phlei was isolated. RESULTS: Of the above CRD patients, 22 were identified as having IPA, accounting for 22.9% of the total CRD. Of the 22 CRD & IPA patients, 5 were confirmed, 13 were clinically diagnosed and 4 were diagnosed, accounting for 22.7%, 59.1% and 18.2% of patients with CRD & IPA, respectively. CONCLUSIONS: CRD & IPA are not rare symptoms and their prognosis is poor. Therefore, the diagnosis of CRD & IPA needs to be strengthened so that the doctor can determine the treatment plan as soon as possible.